News: Cancer Research

Next Page »

Aspirin’s Protective Effect in Cancer Explained

Thursday, October 2nd, 2014

For years, scientists have known that regular aspirin use may reduce the risk of cancer. “Studies have shown that aspirin administration for five or more years reduces the incidence of all cancers by 38 percent,” said Pierre Massion, M.D., professor of Medicine and Cancer Biology and director of the Thoracic Program at Vanderbilt-Ingram Cancer Center. […]

Report Calls for Added Cancer Research Support

Thursday, September 25th, 2014

The American Association for Cancer Research (AACR) Cancer Progress Report 2014, released Sept. 16, details advances in cancer research and treatment — and calls for increased research support.

Accuracy of Lung Imaging Varies by Region

Wednesday, September 24th, 2014

FDG-PET technology is less accurate in diagnosing lung cancer versus benign disease in regions where infections like histoplasmosis or tuberculosis are common, a recent study has found.

Grant Spurs Lung Cancer Surgery Research

Thursday, September 18th, 2014

Joe B. (Bill) Putnam Jr., M.D., Ingram Professor of Cancer Research and chair of the Department of Thoracic Surgery, and colleague Felix Fernandez, M.D., assistant professor of Surgery, Emory University School of Medicine, Atlanta, have received a grant to investigate the most effective forms of surgery to treat lung cancer patients.

Engelhardt Lands Stem Cell Transplant Grant

Thursday, September 11th, 2014

Brian Engelhardt, M.D., MSCI, assistant professor of Medicine, has received a Mentored Career Development Award from the National Heart, Lung, and Blood Institute, a division of the National Institutes of Health, to explore the causes of post-transplant diabetes development.

Lung Cancer Study Reveals New Drug Targets

Thursday, September 4th, 2014

Lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways, a recent study suggests.

Study Creates New Road Map for Cell Activity

Thursday, September 4th, 2014

Human cells are constructed in large part from proteins whose activity can be altered by the incorporation of oxygen in what are known as redox modifications. Detecting these redox modifications as they occur in proteins is delicate work, “like trying to catch a fairy in a jar,” said Daniel Liebler, Ph.D., Ingram Professor of Cancer […]

Limiting Breast Cancer Metastasis

Thursday, August 28th, 2014

Targeting a cytokine pathway may offer a way to inhibit breast cancer cell survival and metastasis, study suggests.

Study identifies genes tied to colon cancer

Friday, August 22nd, 2014

by Dagny Stuart Colorectal cancer is one of the leading causes of death among populations around the world. While diet, physical activity and other lifestyle factors can influence the risk of developing the disease, hereditary factors also play an important role. Genetic factors identified to date explain only a small fraction of colorectal cancer (CRC), […]

Komen breast cancer research grants

Friday, August 1st, 2014

by Dagny Stuart Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation. Justin Balko, Ph.D., Pharm.D., research assistant professor of Medicine, won support for his research project which will use molecular profiling to prioritize adjuvant targeted therapy for triple negative breast […]